Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases (original) (raw)
Updates on the pathologic diagnosis and classification of mesothelioma
Mark Sharobim, Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment Advanced, 2022
View PDFchevron_right
Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
Kristina Kjærheim
2010
View PDFchevron_right
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers
Doug Case
Modern Pathology, 2004
View PDFchevron_right
Mesothelioma and mesothelin—an underused diagnostic biomarker becoming a treatment target
Oluf Dimitri Røe
Shanghai Chest
View PDFchevron_right
Malignant Mesothelioma vs. Reactive Mesothelial Proliferations: Immunohistochemical Profile
Valeria Denninghoff
British Journal of Medicine and Medical Research, 2014
View PDFchevron_right
Malignant biphasic peritoneal mesothelioma in a child: Fine-needle aspiration cytology, Histopathology, and immunohistochemical features along with review of literature
Deepak Bansal
Diagnostic Cytopathology, 2012
View PDFchevron_right
Malignant peritoneal mesothelioma: a review
Glenn Broeckx
Translational Lung Cancer Research
View PDFchevron_right
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
Almog Ben-Yaacov
European Journal of Surgical Oncology, 2020
View PDFchevron_right
Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
Lucia Bisceglia
Clinical Chemical Laboratory Medicine, 2007
View PDFchevron_right
Mesothelioma, Mesothelial Proliferations, and Their Mimics: A Multimodal Approach—Society for Ultrastructural Pathology Companion Meeting at United States and Canadian Academy of Pathology Annual Session in San Antonio, February 2005
John Hicks
Ultrastructural Pathology, 2006
View PDFchevron_right
Challenges in the diagnosis and treatment of peritoneal mesothelioma: a case study and review of the literature
Joanna Szpor
Oncology in Clinical Practice
View PDFchevron_right
Advances in malignant peritoneal mesothelioma
Dian Ding
International journal of colorectal disease, 2015
View PDFchevron_right
Primary malignant mesothelioma of the peritoneum: A clinical and immunohistochemical study
N. Jojic
Gynecologic …, 2005
View PDFchevron_right
Malignant mesothelioma with prominent adenomatoid features: a clinicopathologic and immunohistochemical study of 10 cases
Neda Kalhor
Annals of Diagnostic Pathology, 2011
View PDFchevron_right
Malignant peritoneal mesothelioma: clinicopathological characteristics of two cases
Zulfu Bayhan
Case reports in surgery, 2014
View PDFchevron_right
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
Hadi Yaziji
Modern Pathology, 2006
View PDFchevron_right
Reply to The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions
Farnaz Hasteh
Cancer Cytopathology, 2010
View PDFchevron_right
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Socie
Claire Michael
Diagnostic Cytopathology, 2015
View PDFchevron_right
Peritoneal atypical mesothelial proliferation with progression to invasive mesothelioma: a case report and review of the literature
Gamal Eltabbakh
Pathology, 2003
View PDFchevron_right
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication
Pinar Firat
Cytopathology, 2015
View PDFchevron_right
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Emanuela Felley-Bosco
CA: A Cancer Journal for Clinicians, 2019
View PDFchevron_right
Multidisciplinary Approach to Diagnosing and Managing a Case of Peritoneal Mesothelioma
Jonathan Maw
2020
View PDFchevron_right
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis
Claire Michael
Pathology, 2021
View PDFchevron_right
A Case of Malignant Peritoneal Mesothelioma with an Atypical Clinic Profile
Cuneyt Tetikkurt
2020
View PDFchevron_right
Clinical and pathological features are still the best determinants of prognosis in mesothelioma
Andrew Miller
Oncology (Williston Park, N.Y.), 2012
View PDFchevron_right
Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium
Tatsuki Kataoka
Modern Pathology, 2010
View PDFchevron_right
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
Claire Michael
CytoJournal, 2015
View PDFchevron_right
Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide
ida galise
The International Journal of Biological Markers, 2011
View PDFchevron_right
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma
Claire Michael
Acta Cytologica, 2015
View PDFchevron_right
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference
Robert Taub
Annals of Oncology, 2006
View PDFchevron_right
A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma
Emma Keenan
BMC cancer, 2018
View PDFchevron_right
Peritoneal (Paraovarian) Malignant Mesothelioma
erna kristiani
Medicinus
View PDFchevron_right